Pharmaceutical

AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine  

The company revealed the data at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference 2024.

Mar 9, 2024 - 18:00
AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine  
The company revealed the data at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference 2024.
Read the original article

Tags:

Previous Article

BeiGene secures accelerated FDA approval for follicular lymphoma treatment

Next Article

Amylyx considers scrapping ALS drug following Phase III flop

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Birmingham University to develop lollipop for mouth cancer detection

Birmingham University to develop lollipop for mouth can...

Mar 26, 2024

Immune Thrombocytopenia by NovelMed Therapeutics for Id...

Jul 1, 2023

Opinion: The end of affirmative action means it’s time to revise pre-med requirements

Opinion: The end of affirmative action means it’s time ...

Nov 11, 2023